When QTc is misleading: reversible flecainide-induced left bundle branch block in persistent atrial fibrillation
Drugs in Context · 17.08.2026 · 1
DOI: 10.7573/dic.2026-6-14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs in Context, online erschienen am 17.08.2026. Verfasst von Edgardo Kaplinsky. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A 71-year-old man was referred after asymptomatic atrial fibrillation (AF) was incidentally detected during transthoracic echocardiography that showed a preserved left ventricular systolic function with severe left atrial enlargement (antero-posterior diameter 57 mm; area 49 cm²). Therefore, oral anticoagulation with apixaban (5 mg twice daily) and rhythm-control therapy with flecainide (100 mg twice daily) were initiated. After 2 months, AF persisted but flecainide caused a complete left bundle branch block. QRS duration increased from 88 to 155 ms (+76%), QT from 363 to 427 ms, and QTc from 427 to 535 ms, while the JT interval remained unchanged (275 vs 272 ms). This indicated that the QT prolongation was mainly due to delayed depolarisation rather than altered repolarisation. Suspecting use‑dependent sodium channel blockade, flecainide was stopped. Within 48 hours, ECG showed full resolution of the left bundle branch block, a narrow QRS and normal QT (Figure 1). Flecainide’s main ECG effect is use‑dependent sodium channel blockade with QRS widening, while its impact on repolarization is minimal. Apparent QT prolongation with marked QRS widening should therefore be interpreted cautiously. Guidelines advise ECG monitoring after starting flecainide, and a >25% QRS increase should prompt dose reduction or discontinuation. This case shows how serial ECGs and JT interval assessment help distinguish excessive sodium channel blockade from true repolarization abnormalities and avoid overestimating proarrhythmic risk.
Zitieren
APA
Kaplinsky, E. (2026). When QTc is misleading: reversible flecainide-induced left bundle branch block in persistent atrial fibrillation. Drugs in Context, 1. https://doi.org/10.7573/dic.2026-6-14
Vancouver
Kaplinsky E. When QTc is misleading: reversible flecainide-induced left bundle branch block in persistent atrial fibrillation. Drugs in Context. 2026:1. doi:10.7573/dic.2026-6-14
BibTeX
@article{Kaplinsky2026,
author = {Kaplinsky, Edgardo},
title = {When QTc is misleading: reversible flecainide-induced left bundle branch block in persistent atrial fibrillation},
journal = {Drugs in Context},
year = {2026},
pages = {1},
doi = {10.7573/dic.2026-6-14}
}
EUVIMED